← Leaderboards
Chad Alan Newton
Ut Southwestern Medical Center
$1,662,726
Attributed
$1,662,726
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $771.8K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,662,726 · 2
By mechanism
K23$890,975 · 1
R01$771,751 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Bryce Balmain$519,088
- F. Kent Hamra$8,027,244
- Raksha Jain$1,598,097
- Brenton G. Cooper$1,484,076
Others in their field
Other Emerging Leaders on “Molecular Marker”
- Leonard Freedman · Leidos Biomedical Research, Inc.$289,447,688
- Lynn Briscoe · Leidos Biomedical Research, Inc.$116,524,368
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$62,460,972
- Leonard Freedmand · Leidos Biomedical Research, Inc.$57,936,170
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
Research focus
Molecular MarkerFoundationsPredictive ModelingCohortBloodDesignHigh RiskPhenotypeDisease ProgressionTelomereIdiopathic Pulmonary FibrosisEnvironmentBiologicalDisorder RiskBioinformaticsAcuteEnvironmental ExposureChromatin StructureChromatinArchitectureDyspneaBehaviorCigarette SmokeCessation Of Life
Grant awards (6)
The Prognostic and Predictive Impact of Telomere Length in Fibrotic Interstitial Lung Disease$771,751
R01 · FY2025 · HL · contact PI
Molecular Markers of Idiopathic Pulmonary Fibrosis Progression$178,195
K23 · FY2024 · HL · contact PI
Molecular Markers of Idiopathic Pulmonary Fibrosis Progression$178,195
K23 · FY2023 · HL · contact PI
Molecular Markers of Idiopathic Pulmonary Fibrosis Progression$178,195
K23 · FY2022 · HL · contact PI
Molecular Markers of Idiopathic Pulmonary Fibrosis Progression$178,195
K23 · FY2021 · HL · contact PI
Molecular Markers of Idiopathic Pulmonary Fibrosis Progression$178,195
K23 · FY2020 · HL · contact PI